Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
University of Nova Gorica
University
Study
Research
Repository of University of Nova Gorica
About
Search
Browse
Statistics
Login
Show document
A+
|
A-
|
|
SLO
|
ENG
Title:
Phage display and Shiga toxin neutralizers
Authors:
ID
Bernedo Navarro, Robert Alvin
, University of Nova Gorica (Author)
ID
Yano, Tomomasa
, Universidade Estadual de Campinas (Author), et al.
Files:
This document has no files that are freely available to the public. This document may have a physical copy in the library of the organization, check the status via
COBISS.
Language:
English
Work type:
Not categorized
Typology:
1.02 - Review Article
Organization:
UNG - University of Nova Gorica
Keywords:
Shiga toxins
,
phage display
Publication version:
Version of Record
Year of publishing:
2016
Number of pages:
60-69
Numbering:
113
PID:
20.500.12556/RUNG-4544-b459d9e4-1a37-f2ff-1d4b-af78ab4b652d
COBISS.SI-ID:
5391355
NUK URN:
URN:SI:UNG:REP:7U2KPCM6
Publication date in RUNG:
27.05.2019
Views:
4339
Downloads:
0
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
BERNEDO NAVARRO, Robert Alvin and YANO, Tomomasa, 2016, Phage display and Shiga toxin neutralizers.
Toxicon
[online]. 2016. Vol. 113, p. 60–69. [Accessed 3 April 2025]. Retrieved from: https://repozitorij.ung.si/IzpisGradiva.php?lang=eng&id=4544
Copy citation
Average score:
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
(0 votes)
Your score:
Voting is allowed only for
logged in
users.
Share:
Similar works from our repository:
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Multicenter evaluation of the fully automated PCR-based Idylla EGFR Mutation Assay on formalin-fixed, paraffin-embedded Q1 tissue of human lung cancer
Pomen mutacije gena receptorja za epidermalni rastni dejavnik za zdravljenje nedrobnoceličnega raka pljuč
Novosti v zdravljenju pljučnega raka ASCO, Chicago, 1.-5. junij 2012
Similar works from other repositories:
Uporabnost imunohistokemičnega določanja mutacij receptorja za epidermalni rastni faktor pri raku pljuč
Pregled zdravljenja bolnikov z napredovalnim nedrobnoceličnim pljučnim rakom z mutacijami v receptorju za epidermalni rastni dejavnik med leti 2010 in 2014 na Univerzitetni kliniki Golnik
Proučevanje izražanja gena za fosfatidiletanolamin-N-metiltransferazo v nedrobnoceličnem pljučnem rakavem tkivu
Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
Razvoj imunohistokemične metode za celični označevalec CD163 na celicah z visokim izražanjem lipoproteinske lipaze v nedrobonceličnem pljučnem rakavem tkivu
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.
Record is a part of a journal
Title:
Toxicon
Year of publishing:
2016
Back